About Us
DevPro Biopharma is a Clinical Research and Development Accelerator with the mission to design, develop, and deliver molecules into medicines.
Our corporate vision is to be a force for continual change in clinical development, focused on bringing medicines to people faster and more efficiently.
Our corporate vision is to be a force for continual change in clinical development, focused on bringing medicines to people faster and more efficiently.
DevPro Biopharma’s unique capabilities allow the team to span full development programs, with focus on the complete development cycle through global
regulatory approvals.
WHY DEVPRO BIOPHARMA:
DevPro Biopharma is a fully integrated, stand-alone clinical development accelerator company with:
- Track record of leading a start up company, Pearl Therapeutics, with an initial $15M Series A investment into a $1.5Bn acquisition by AZN in ~5½ years
- World class development team with a proven track record of successfully leading productions to regulatory approvals
– We are industry leaders in the development of respiratory productions including inhaled medicines. - Provent internal clinical exectution model that de-risks development, optimizes cost, and accelerates approval
- Global reach including simultaneous development to support approval in China, Japan, US and EU (Breztri Aerosphere)
- Leadership and manager team with deep experience building start-ups and operating big-pharma organizations
